2017
DOI: 10.1097/mpa.0000000000000752
|View full text |Cite
|
Sign up to set email alerts
|

Thrombopoietin as Early Biomarker of Disease Severity in Patients With Acute Pancreatitis

Abstract: Our data provide the first evidence for TPO as potential early prognostic biomarker in AP patients. High TPO levels at hospital admission may predict organ dysfunction, sepsis, and fatal outcome in AP patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 46 publications
0
4
0
Order By: Relevance
“… 46 Interestingly, one of the mechanisms that may sustain increased THPO levels in inflammatory systemic diseases is represented by augmented hepatic synthesis stimulated by IL-6. 47 Furthermore, disease severity is a major determinant of elevated THPO levels in patients affected by sepsis 48 or acute pancreatitis, 49 suggesting that THPO may be proposed as a potential prognostic marker in these pathologic conditions.…”
Section: Introductionmentioning
confidence: 99%
“… 46 Interestingly, one of the mechanisms that may sustain increased THPO levels in inflammatory systemic diseases is represented by augmented hepatic synthesis stimulated by IL-6. 47 Furthermore, disease severity is a major determinant of elevated THPO levels in patients affected by sepsis 48 or acute pancreatitis, 49 suggesting that THPO may be proposed as a potential prognostic marker in these pathologic conditions.…”
Section: Introductionmentioning
confidence: 99%
“…AP patients develops severe AP (SAP) with a mortality rate approximately 30% [3]. SAP is characterized by multiple organ failure as well as necrosis of the pancreas and the surrounding tissues [4].…”
mentioning
confidence: 99%
“…Due to the facet of rapid deterioration and high mortality of SAP, early identification of disease severity becomes essential for the evaluation of clinical treatment and the management of SAP [5]. Many multi-factoring scoring systems such as acute physiology and chronic health evaluation II (APACHE II) score and Ranson score have been widely applied for assessing SAP severity and predicting prognosis in clinical practice [3,6]. However, under some circumstances such as at the time of initial presentation of SAP, the use of APACHE II score and Ranson score may be complex and with low sensitivity [3,7].…”
mentioning
confidence: 99%
See 1 more Smart Citation